Collateralized Loan Obligations (CLOs)

Showing 214 articles
Business

Bausch Health's Deep Discount: Market Overshoot or Justified Skepticism?

With shares languishing near $5.74, Bausch Health Companies (BHC) presents a stark valuation puzzle. While a standard DCF model suggests a staggering 91% undervaluation, the market's persistent sell-off reflects deep-seated concerns over the company's restructuring path and debt burden. We examine the numbers behind the divergence.

Business

First Hawaiian Bank's Valuation Under Scrutiny Amid Volatile Trading

First Hawaiian Bank (FHB) shares have captured investor interest following a period of mixed performance, trading at $26.55. While recent daily declines contrast with solid monthly and quarterly gains, analysts debate whether the stock's current discount to intrinsic value represents a buying opportunity or reflects underlying economic risks.